Crystal Structure of an LSD-Bound Human Serotonin Receptor

Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., ... & Shoichet, B. K. | Cell | 26 January 2017

Harmine stimulates proliferation of human neural progenitors

Dakic, V., de Moraes Maciel, R., Drummond, H., Nascimento, J. M., Trindade, P., & Rehen, S. K. | PeerJ | 6 December 2016

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT

Ma, K. H., Liu, T. T., Weng, S. J., Chen, C. F. F., Huang, Y. S., Chueh, S. H., ... & Huang, W. S. | Scientific Reports | 1 December 2016

Ecstasy research: will increasing observational data aid our understanding of MDMA?

Amoroso, T. | The Lancet Psychiatry | 1 December 2016

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

De Gregorio, D., Comai, S., Posa, L., & Gobbi, G. | International Journal of Molecular Sciences | 23 November 2016

Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant

Zhu, W., Ding, Z., Zhang, Y., Shi, J., Hashimoto, K., & Lu, L. | Neuroscience Bulletin | 22 November 2016

Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., & Murnane, K. S. | Journal of Psychopharmacology | 15 November 2016


Jyothi, P., & Yellamma, K. | International Journal of Pharmacy and Pharmaceutical Sciences | 1 November 2016

Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Neuroscience & Biobehavioral Reviews | 31 October 2016

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells

Szabo, A., Kovacs, A., Riba, J., Djurovic, S., Rajnavolgyi, E., & Frecska, E. | Frontiers in Neuroscience | 14 September 2016

Ketamine Treatment and Global Brain Connectivity in Major Depression

Abdallah, C. G., Averill, L. A., Collins, K. A., Geha, P., Schwartz, J., Averill, C., ... & Iosifescu, D. V. | Neuropsychopharmacology | 8 September 2016

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies

Vegting, Y., Reneman, L., & Booij, J. | Psychopharmacology | 28 August 2016

The antidepressant effect of ketamine: Mediated by AMPA receptors?

Inta, D., Sprengel, R., Borgwardt, S., Lang, U. E., & Gass, P. | European Neuropsychopharmacology | 20 August 2016

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. | Pharmacological Research | 17 August 2016

Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study

Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016

Neurovascular Plasticity of the Hippocampus One Week after a Single Dose of Ketamine in Genetic Rat Model of Depression

Ardalan, M., Wegener, G., Polsinelli, B., Madsen, T. M., & Nyengaard, J. R. | Hippocampus | 21 July 2016

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience

Gallimore, A. R. and Strassman, R. | Frontiers in Pharmacology | 30 June 2016

Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors

Ponzoni, L., Daniela, B., & Sala, M. | Psychopharmacology | 16 June 2016

Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Colestock, T., ... & Halberstadt, A. L. | Drug testing and analysis | 6 June 2016

Serotonin antagonists fail to alter MDMA self-administration in rats

Schenk, S., Foote, J., Aronsen, D., Bukholt, N., Highgate, Q., Van de Wetering, R., & Webster, J. | Pharmacology Biochemistry and Behavior | 2 June 2016

Potential involvement of serotonergic signaling in ketamine’s antidepressant actions: A critical review

du Jardin, K. G., Müller, H. K., Elfving, B., Dale, E., Wegener, G., & Sanchez, C. | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2 June 2016

Ketamine abuse potential and use disorder

Liu, Y., Lin, D., Wu, B., & Zhou, W. | Brain research bulletin | 31 May 2016

Ibogaine and addiction in the animal model, a systematic review and meta-analysis

Belgers, M., Leenaars, M., Homberg, J. R., Ritskes-Hoitinga, M., Schellekens, A. F. A., & Hooijmans, C. R. | Translational psychiatry | 31 May 2016

Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans

Nunes, A. A., dos Santos, R. G., Osório, F. L., Sanches, R. F., Crippa, J. A. S., & Hallak, J. E. | Journal of psychoactive drugs | 26 May 2016